Skip to main content

Table 2 Comparison of the effect estimates on the desired outcomes between previous [12] and updated meta-analysis following addition of new studies for the selected early stage cervical cancer groups

From: Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis

Outcome/type of therapy New studies included in the updated meta-analysis
(author & year of publication)
Surgery Effect Estimate with 95% CI
2021 vs 2014 [12]
Surgery ± BR Effect Estimate with 95% CI
2021 vs 2014 [12]
Surgery ± BR ± EBRT Effect Estimate with 95% CI
2021 vs 2014 [12]
Preserved Ovarian Function Du Z [33] 2017
Hoeckman [35] 2018 Swift [34] 2018
0.91 (0.83 to 1.00)
vs
0.91 (0.82 to 1.00)
None No change Du Z [33] 2017
Hoeckman [35] 2018
Lv [41] 2019
Shou [40] 2015
Swift [34] 2018
Yin L [42] 2019
0.61 (0.55 to 0.69)
vs
0.62 (0.53 to 0.72)
Metastases Zhao [43] 2013 0.02 (0.01 to 0.05)
vs
0.02 (0.00 to 0.08)
None No change None No change
Ovarian Cysts None No change None No change Swift [34] 2018 0.16 (0.10 to 0.27)
vs
0.16 (0.10 to 0.26)